{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "MIRUM PHARMAC.  DL-,0001", "longName": "Mirum Pharmaceuticals, Inc.", "messageBoardId": "finmb_590571226", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 23.8, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.08461542, "fiftyTwoWeekLow": 16.3, "fiftyTwoWeekHigh": 26.0, "earningsTimestamp": 1683232200, "earningsTimestampStart": 1690973940, "earningsTimestampEnd": 1691409600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.44, "epsForward": -3.33, "epsCurrentYear": -5.28, "priceEpsCurrentYear": -4.5075755, "sharesOutstanding": 38031800, "bookValue": 3.713, "fiftyDayAverage": 22.428, "fiftyDayAverageChange": 1.3719997, "fiftyDayAverageChangePercent": 0.061173525, "twoHundredDayAverage": 21.188, "twoHundredDayAverageChange": 2.6119995, "twoHundredDayAverageChangePercent": 0.12327731, "marketCap": 917768448, "forwardPE": -7.147147, "priceToBook": 6.4099107, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683875702, "regularMarketDayHigh": 23.8, "regularMarketDayRange": "23.8 - 23.8", "regularMarketDayLow": 23.8, "regularMarketVolume": 30, "regularMarketPreviousClose": 23.8, "bid": 23.8, "ask": 24.4, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 23.8, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 7.5, "fiftyTwoWeekLowChangePercent": 0.46012273, "fiftyTwoWeekRange": "16.3 - 26.0", "fiftyTwoWeekHighChange": -2.2000008, "firstTradeDateMilliseconds": 1617084000000, "symbol": "08D.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "950 Tower Lane", "address2": "Suite 1050", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 667 4085", "website": "https://www.mirumpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of primary sclerosing cholangitis and primary biliary cholangitis in adults. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.", "fullTimeEmployees": 200, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher  Peetz", "age": 43, "title": "Pres, CEO & Director", "yearBorn": 1979, "fiscalYear": 2022, "totalPay": {"raw": 1085480, "fmt": "1.09M", "longFmt": "1,085,480"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 9402050, "fmt": "9.4M", "longFmt": "9,402,050"}}, {"maxAge": 1, "name": "Mr. Peter  Radovich M.B.A., Ph.D.", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 732150, "fmt": "732.15k", "longFmt": "732,150"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 409254, "fmt": "409.25k", "longFmt": "409,254"}}, {"maxAge": 1, "name": "Dr. Pamela  Vig Ph.D.", "age": 51, "title": "Head of R&D", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 678200, "fmt": "678.2k", "longFmt": "678,200"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3933453, "fmt": "3.93M", "longFmt": "3,933,453"}}, {"maxAge": 1, "name": "Ms. Lara  Longpre MBA, MSC", "age": 52, "title": "Chief Devel. Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 678200, "fmt": "678.2k", "longFmt": "678,200"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3933453, "fmt": "3.93M", "longFmt": "3,933,453"}}, {"maxAge": 1, "name": "Dr. Ian  Clements Ph.D.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul K. Ross", "title": "Chief Compliance Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Erin  Campany", "age": 54, "title": "Sr. VP of HR", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Vinita P. Kumar", "title": "Sr. vice Pres of Quality", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 2, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}